The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG.
 
Shakeel Modak
Consulting or Advisory Role - EUSA Pharma; Illumina; US WorldMeds; Ymabs Therapeutics Inc
Speakers' Bureau - Ymabs Therapeutics Inc
Patents, Royalties, Other Intellectual Property - Two patents pending; no financial benefit
 
Audrey Mauguen
Research Funding - Amgen (Inst); ImaginAb (Inst)
Patents, Royalties, Other Intellectual Property - co-inventor of provisional patent Number 63/193,700, filed on 5/27/21; conversion deadline: 5/27/22; named “Soothsayer”, filed by Office of Technology Development, MSKCC
 
Ellen M. Basu
No Relationships to Disclose
 
Anita Price
No Relationships to Disclose
 
Gerald Behr
No Relationships to Disclose
 
Ryan Min
No Relationships to Disclose
 
Serge K. Lyashchenko
No Relationships to Disclose
 
Jazmin Schwartz
No Relationships to Disclose
 
Neeta Pandit-Taskar
Honoraria - Actinium Pharmaceuticals
Consulting or Advisory Role - Actinium Pharmaceuticals; Fusion Pharmaceuticals; Illumina; progenics
Speakers' Bureau - Actinium Pharmaceuticals
Research Funding - Bayer Health (Inst); Bristol-Myers Squibb (Inst); Clarity Pharmaceuticals (Inst); Fusion Pharmaceuticals (Inst); Imaginab (Inst); Janssen (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Bayer